Release Date: 30/05/16 11:14 Summary: Suspension from Official Quotation-BRS.AX Price Sensitive: Yes Download Document 79.53KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%